Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jim Potenziano
Institution:
Tris Pharma (United States)
Observed institution:
Tris Pharma (United States)
ORCID:
0009-0007-0424-2882
Observed ORCID:
0009-0007-0424-2882
OpenAlex ID:
A5107263732
The burden of acute pain in the U.S. in the wake of the opioid crisis
2025
·
James C. Hackworth
, John E. Schneider
, et al.
·
Frontiers in Pain Research
·
8
PDF
The Therapeutic Potential of Dual NMR (NOP/MOP) Agonism in Pain Management
2025
·
Roberto Ciccocioppo
, Jeffrey Gudin
, et al.
·
Pain and Therapy
·
6
PDF
Economic Evaluation of a Novel Treatment of Attention-Deficit/Hyperactivity Disorder in US Motor Vehicle Drivers
2024
·
Jacie T. Cooper
, John E. Schneider
, et al.
·
Journal of health economics and outcomes research
·
2
Measuring the Effect of Amphetamine Extended-Release (DYANAVEL® XR) on Driving Performance in Young Adult Drivers with ADHD Using a Sophisticated Driving Simulation
2026
·
Craig Surman
, Bruce Mehler
, et al.
·
Advances in Therapy
PDF
Relative Bioavailability of Once-Daily Clonidine XR Oral Suspension Versus Twice-Daily XR Tablets in Healthy Volunteers
2026
·
Rakesh Jain
, Eman Rafla
, et al.
·
Journal of Attention Disorders
Correction: The Impact of Untreated Attention-Deficit/Hyperactivity Disorder on Motor Vehicle Accidents: A Systematic Review and Meta-Analysis
2026
·
Ann Childress
, Hirah Malik
, et al.
·
Advances in Therapy
PDF
The Economic burden of opioid-related serious adverse events and undertreatment of acute pain in the United States
2026
·
James C. Hackworth
, John E. Schneider
, et al.
·
Frontiers in Public Health
PDF
The Impact of Untreated Attention-Deficit/Hyperactivity Disorder on Motor Vehicle Accidents: A Systematic Review and Meta-Analysis
2026
·
Ann Childress
, Hirah Malik
, et al.
·
Advances in Therapy
PDF
The Impact of Untreated Attention-Deficit/Hyperactivity Disorder on Motor Vehicle Accidents
2026
·
Ann Childress
, Hirah Malik
, et al.
Economic Evaluation of Extended-Release Amphetamine (Dyanavel XR) Among Individuals with Attention-Deficit/Hyperactivity Disorder From a United States Societal Perspective
2025
·
Ishveen Chopra
, Jennifer Horng
, et al.
·
ClinicoEconomics and Outcomes Research
PDF
Show more works
View as search
Works count:
10
Citation count:
16
H-index:
2
I10-index:
Year
Topic
Type